Medtronic PLC vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Medtronic PLC trades at $88.22 (market cap $112.24B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.68 (market cap $330.98M). The key difference: Medtronic PLC is far larger — about 339.1× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and Medtronic PLC pays a 3.28% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.
| MDT | XDTE | |
|---|---|---|
Market Cap | $112.24B | $330.98M |
Volume | 105,663,236 | 194,030 |
Sector | Health | Income / Options Overlay |
52-Week High | $105.35 | $44.76 |
52-Week Low | $73.75 | $36.00 |
Typical Hold Time | 63 Days | 54 Days |
Enterprise Value | $131.58B | — |
Dividend Yield | 3.28% | — |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.80, up 2.68% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 13.93% net income margin and consistent dividend growth over 49 years. Revenue growth accelerated to $33.54B in 2025, and analyst consensus targets $97.80, implying 11% upside. Recent news highlights regulatory approvals for medical devices and a $4B MiniMed exchange offer.
MDT offers value with a 3.2% dividend yield and reasonable valuation (P/E 21.6), but faces headwinds from technical bearishness and rising debt. The stock's appeal hinges on execution of growth initiatives in cardiovascular and neuroscience segments, though competitive and macroeconomic risks persist.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →